Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Wikipedia
GILD (NasdaqGS) $66.59 -1.81 (-2.65%)
Wed, Jul 3, 2024, 1:00PM EDT